Lived Experiences of Women Diagnosed With HPV Infection
Living Between Fear and Uncertainty: The Lived Experiences of Women Diagnosed With HPV Infection - A Phenomenological Study
This qualitative phenomenological study aims to explore the lived experiences of women diagnosed with human papillomavirus (HPV) infection. The study will examine women's emotional responses to the diagnosis, its perceived effects on daily life, sexual life and partner relationships, their experiences of disclosing the diagnosis, and their information and support needs. Eligible women diagnosed with HPV infection will participate in individual semi-structured interviews. The interview data will be analyzed thematically to identify common themes reflecting participants' experiences and perceptions.
Tutkimuksen yleiskatsaus
Tila
Interventio / Hoito
Yksityiskohtainen kuvaus
This study is designed as a qualitative phenomenological study to gain an in-depth understanding of the lived experiences of women diagnosed with HPV infection. Participants will be adult women with a confirmed HPV diagnosis who meet the eligibility criteria and provide written informed consent.
Data will be collected through individual face-to-face semi-structured interviews. The interview guide explores participants' experiences from the time of HPV diagnosis, emotional responses, perceived effects on daily and sexual life, partner relationships and disclosure experiences, concerns regarding future health, experiences with healthcare professionals, and perceived information and support needs. Interviews are expected to last approximately 30-45 minutes and will be audio-recorded with participants' permission.
Data collection will continue until data saturation is achieved, with approximately 15-20 participants anticipated. Interview recordings will be transcribed and analyzed thematically. Participant identities will be protected through coding, and personally identifying information will not be included in the analysis or reporting of the findings.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Ahmet Demirci, MD
- Puhelinnumero: +905418807091
- Sähköposti: ahmet.demirci@bilecik.edu.tr
Opiskelupaikat
-
-
Bilecik
-
Bilecik, Bilecik, Turkki (Türkiye), 11230
- Rekrytointi
- Bilecik Training and Research Hospital
-
Alatutkija:
- Aysun Acun, PhD
-
Ottaa yhteyttä:
- Ahmet Demirci, MD
- Puhelinnumero: +905418807091
- Sähköposti: ahmet.demirci@bilecik.edu.tr
-
Alatutkija:
- Büşra Küçüktürkmen, PhD
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Näytteenottomenetelmä
Tutkimusväestö
Adult women aged 18 years or older with a confirmed HPV infection who meet the eligibility criteria and voluntarily agree to participate in the study. Participants will be recruited among women evaluated at the study center and will undergo individual semi-structured interviews regarding their lived experiences following HPV diagnosis.
Kuvaus
Inclusion Criteria:
- Confirmed diagnosis of HPV infection by HPV DNA testing
- Ability to communicate verbally in Turkish
- Willingness to participate in an individual semi-structured interview
- Provision of written informed consent
Exclusion Criteria:
- Inability to communicate adequately in Turkish
- Cognitive or communication difficulties that would prevent participation in the interview
- Refusal or withdrawal of informed consent
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Havaintomallit: OTHER
- Aikanäkymät: PROSPECTIVE
Kohortit ja interventiot
Ryhmä/Kohortti |
Interventio / Hoito |
|---|---|
|
Women Diagnosed With HPV Infection
Adult women aged 18 years or older with a confirmed HPV infection who meet the eligibility criteria and provide written informed consent. Participants will take part in individual semi-structured interviews exploring their lived experiences following HPV diagnosis. |
Participants will take part in an individual face-to-face semi-structured interview exploring their lived experiences following HPV diagnosis, including emotional responses, daily and sexual life, partner relationships, disclosure experiences, future health concerns, experiences with healthcare professionals, and information and support needs. Interviews are expected to last approximately 30-45 minutes and will be audio-recorded with participants' permission. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Lived Experiences of Women Diagnosed With HPV Infection
Aikaikkuna: At least 4 weeks after HPV diagnosis, following the initial acute adjustment period, during a single 30-45-minute semi-structured interview.
|
Participants' lived experiences following HPV diagnosis will be explored through individual semi-structured interviews. Interview transcripts will be analyzed thematically to identify themes related to emotional responses, daily and sexual life, partner relationships, disclosure experiences, future health concerns, interactions with healthcare professionals, and information and support needs. |
At least 4 weeks after HPV diagnosis, following the initial acute adjustment period, during a single 30-45-minute semi-structured interview.
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Päätutkija: Ahmet Demirci, Bilecik Seyh Edebali University Faculty of Medicine
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- HPV-PHEN-2026-01
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
Individual participant data will not be publicly shared due to the qualitative nature of the study and the potential risk of identifying participants from interview data. Data will be kept confidential and used only for the purposes of this study.
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .